Volume 58, Issue 10 pp. 3151-3155
Communication

Biocatalytic Friedel–Crafts Alkylation Using a Promiscuous Biosynthetic Enzyme

Prof. Erica E. Schultz

Prof. Erica E. Schultz

Department of Chemistry, Lake Forest College, 555 Sheridan Rd, Lake Forest, IL, 60045 USA

These authors contributed equally to this work.

Search for more papers by this author
Nathaniel R. Braffman

Nathaniel R. Braffman

Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford St., Cambridge, MA, 02138 USA

These authors contributed equally to this work.

Search for more papers by this author
Dr. Michael U. Luescher

Dr. Michael U. Luescher

Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford St., Cambridge, MA, 02138 USA

Search for more papers by this author
Harry H. Hager

Harry H. Hager

Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford St., Cambridge, MA, 02138 USA

Search for more papers by this author
Prof. Emily P. Balskus

Corresponding Author

Prof. Emily P. Balskus

Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford St., Cambridge, MA, 02138 USA

Search for more papers by this author
First published: 01 February 2019
Citations: 43

Graphical Abstract

Enzymatic alkylation: The cylindrocyclophane biosynthetic enzyme CylK is identified as a promiscuous catalyst for Friedel–Crafts alkylation of resorcinol substrates with alkyl halide electrophiles. This transformation, which proceeds with exceptional regioselectivity and stereospecificity, highlights the promise of enzymatic catalysis for enabling mild and selective C−C bond-forming synthetic methodology.

Abstract

The Friedel–Crafts alkylation is commonly used in organic synthesis to form aryl–alkyl C−C linkages. However, this reaction lacks the stereospecificity and regiocontrol of enzymatic catalysis. Here, we describe a stereospecific, biocatalytic Friedel–Crafts alkylation of the 2-position of resorcinol rings using the cylindrocyclophane biosynthetic enzyme CylK. This regioselectivity is distinct from that of the classical Friedel–Crafts reaction. Numerous secondary alkyl halides are accepted by this enzyme, as are resorcinol rings with a variety of substitution patterns. Finally, we have been able to use this transformation to access novel analogues of the clinical drug candidate benvitimod that are challenging to construct with existing synthetic methods. These findings highlight the promise of enzymatic catalysis for enabling mild and selective C−C bond-forming synthetic methodology.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.